Global Rare Disease Genetic Testing Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Rare Disease Genetic Testing Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Next-Generation Sequencing (NGS)
  • 1.2.3 Array Technology
  • 1.2.4 PCR-based Testing
  • 1.2.5 Fluorescence in Situ Hybridization (FISH)
  • 1.2.6 Sanger Sequencing
  • 1.2.7 Karyotyping
  • 1.2.8 Others
• 1.3 Market by Application
  • 1.3.1 Global Rare Disease Genetic Testing Market Share by Application: 2020 VS 2026
  • 1.3.2 Research Laboratories and CROs
  • 1.3.3 Diagnostic Laboratories
  • 1.3.4 Hospitals and Clinics
  • 1.3.5 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Rare Disease Genetic Testing Market Perspective (2015-2026)
• 2.2 Global Rare Disease Genetic Testing Growth Trends by Regions
  • 2.2.1 Rare Disease Genetic Testing Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Rare Disease Genetic Testing Historic Market Share by Regions (2015-2020)
  • 2.2.3 Rare Disease Genetic Testing Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Rare Disease Genetic Testing Players by Market Size
  • 3.1.1 Global Top Rare Disease Genetic Testing Players by Revenue (2015-2020)
  • 3.1.2 Global Rare Disease Genetic Testing Revenue Market Share by Players (2015-2020)
• 3.2 Global Rare Disease Genetic Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Rare Disease Genetic Testing Revenue
• 3.4 Global Rare Disease Genetic Testing Market Concentration Ratio
  • 3.4.1 Global Rare Disease Genetic Testing Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Rare Disease Genetic Testing Revenue in 2019
• 3.5 Key Players Rare Disease Genetic Testing Area Served
• 3.6 Key Players Rare Disease Genetic Testing Product Solution and Service
• 3.7 Date of Enter into Rare Disease Genetic Testing Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Rare Disease Genetic Testing Breakdown Data by Type (2015-2026)

• 4.1 Global Rare Disease Genetic Testing Historic Market Size by Type (2015-2020)
• 4.2 Global Rare Disease Genetic Testing Forecasted Market Size by Type (2021-2026)

5 Rare Disease Genetic Testing Breakdown Data by Application (2015-2026)

• 5.1 Global Rare Disease Genetic Testing Historic Market Size by Application (2015-2020)
• 5.2 Global Rare Disease Genetic Testing Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Rare Disease Genetic Testing Market Size (2015-2026)
• 6.2 North America Rare Disease Genetic Testing Market Size by Type (2015-2020)
• 6.3 North America Rare Disease Genetic Testing Market Size by Application (2015-2020)
• 6.4 North America Rare Disease Genetic Testing Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Rare Disease Genetic Testing Market Size (2015-2026)
• 7.2 Europe Rare Disease Genetic Testing Market Size by Type (2015-2020)
• 7.3 Europe Rare Disease Genetic Testing Market Size by Application (2015-2020)
• 7.4 Europe Rare Disease Genetic Testing Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Rare Disease Genetic Testing Market Size (2015-2026)
• 8.2 China Rare Disease Genetic Testing Market Size by Type (2015-2020)
• 8.3 China Rare Disease Genetic Testing Market Size by Application (2015-2020)
• 8.4 China Rare Disease Genetic Testing Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Rare Disease Genetic Testing Market Size (2015-2026)
• 9.2 Japan Rare Disease Genetic Testing Market Size by Type (2015-2020)
• 9.3 Japan Rare Disease Genetic Testing Market Size by Application (2015-2020)
• 9.4 Japan Rare Disease Genetic Testing Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Rare Disease Genetic Testing Market Size (2015-2026)
• 10.2 Southeast Asia Rare Disease Genetic Testing Market Size by Type (2015-2020)
• 10.3 Southeast Asia Rare Disease Genetic Testing Market Size by Application (2015-2020)
• 10.4 Southeast Asia Rare Disease Genetic Testing Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

• 11.1 Quest Diagnostics
  • 11.1.1 Quest Diagnostics Company Details
  • 11.1.2 Quest Diagnostics Business Overview
  • 11.1.3 Quest Diagnostics Rare Disease Genetic Testing Introduction
  • 11.1.4 Quest Diagnostics Revenue in Rare Disease Genetic Testing Business (2015-2020))
  • 11.1.5 Quest Diagnostics Recent Development
• 11.2 Centogene
  • 11.2.1 Centogene Company Details
  • 11.2.2 Centogene Business Overview
  • 11.2.3 Centogene Rare Disease Genetic Testing Introduction
  • 11.2.4 Centogene Revenue in Rare Disease Genetic Testing Business (2015-2020)
  • 11.2.5 Centogene Recent Development
• 11.3 Invitae Corporation
  • 11.3.1 Invitae Corporation Company Details
  • 11.3.2 Invitae Corporation Business Overview
  • 11.3.3 Invitae Corporation Rare Disease Genetic Testing Introduction
  • 11.3.4 Invitae Corporation Revenue in Rare Disease Genetic Testing Business (2015-2020)
  • 11.3.5 Invitae Corporation Recent Development
• 11.4 3billion
  • 11.4.1 3billion Company Details
  • 11.4.2 3billion Business Overview
  • 11.4.3 3billion Rare Disease Genetic Testing Introduction
  • 11.4.4 3billion Revenue in Rare Disease Genetic Testing Business (2015-2020)
  • 11.4.5 3billion Recent Development
• 11.5 Arup Laboratories
  • 11.5.1 Arup Laboratories Company Details
  • 11.5.2 Arup Laboratories Business Overview
  • 11.5.3 Arup Laboratories Rare Disease Genetic Testing Introduction
  • 11.5.4 Arup Laboratories Revenue in Rare Disease Genetic Testing Business (2015-2020)
  • 11.5.5 Arup Laboratories Recent Development
• 11.6 Eurofins Scientific
  • 11.6.1 Eurofins Scientific Company Details
  • 11.6.2 Eurofins Scientific Business Overview
  • 11.6.3 Eurofins Scientific Rare Disease Genetic Testing Introduction
  • 11.6.4 Eurofins Scientific Revenue in Rare Disease Genetic Testing Business (2015-2020)
  • 11.6.5 Eurofins Scientific Recent Development
• 11.7 Strand Life Sciences
  • 11.7.1 Strand Life Sciences Company Details
  • 11.7.2 Strand Life Sciences Business Overview
  • 11.7.3 Strand Life Sciences Rare Disease Genetic Testing Introduction
  • 11.7.4 Strand Life Sciences Revenue in Rare Disease Genetic Testing Business (2015-2020)
  • 11.7.5 Strand Life Sciences Recent Development
• 11.8 Ambry Genetics
  • 11.8.1 Ambry Genetics Company Details
  • 11.8.2 Ambry Genetics Business Overview
  • 11.8.3 Ambry Genetics Rare Disease Genetic Testing Introduction
  • 11.8.4 Ambry Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
  • 11.8.5 Ambry Genetics Recent Development
• 11.9 Perkin Elmer
  • 11.9.1 Perkin Elmer Company Details
  • 11.9.2 Perkin Elmer Business Overview
  • 11.9.3 Perkin Elmer Rare Disease Genetic Testing Introduction
  • 11.9.4 Perkin Elmer Revenue in Rare Disease Genetic Testing Business (2015-2020)
  • 11.9.5 Perkin Elmer Recent Development
• 11.10 Macrogen
  • 11.10.1 Macrogen Company Details
  • 11.10.2 Macrogen Business Overview
  • 11.10.3 Macrogen Rare Disease Genetic Testing Introduction
  • 11.10.4 Macrogen Revenue in Rare Disease Genetic Testing Business (2015-2020)
  • 11.10.5 Macrogen Recent Development
• 11.11 Baylor Genetics
  • 10.11.1 Baylor Genetics Company Details
  • 10.11.2 Baylor Genetics Business Overview
  • 10.11.3 Baylor Genetics Rare Disease Genetic Testing Introduction
  • 10.11.4 Baylor Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
  • 10.11.5 Baylor Genetics Recent Development
• 11.12 Color Genomics
  • 10.12.1 Color Genomics Company Details
  • 10.12.2 Color Genomics Business Overview
  • 10.12.3 Color Genomics Rare Disease Genetic Testing Introduction
  • 10.12.4 Color Genomics Revenue in Rare Disease Genetic Testing Business (2015-2020)
  • 10.12.5 Color Genomics Recent Development
• 11.13 Preventiongenetics
  • 10.13.1 Preventiongenetics Company Details
  • 10.13.2 Preventiongenetics Business Overview
  • 10.13.3 Preventiongenetics Rare Disease Genetic Testing Introduction
  • 10.13.4 Preventiongenetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
  • 10.13.5 Preventiongenetics Recent Development
• 11.14 Progenity
  • 10.14.1 Progenity Company Details
  • 10.14.2 Progenity Business Overview
  • 10.14.3 Progenity Rare Disease Genetic Testing Introduction
  • 10.14.4 Progenity Revenue in Rare Disease Genetic Testing Business (2015-2020)
  • 10.14.5 Progenity Recent Development
• 11.15 Coopersurgical
  • 10.15.1 Coopersurgical Company Details
  • 10.15.2 Coopersurgical Business Overview
  • 10.15.3 Coopersurgical Rare Disease Genetic Testing Introduction
  • 10.15.4 Coopersurgical Revenue in Rare Disease Genetic Testing Business (2015-2020)
  • 10.15.5 Coopersurgical Recent Development
• 11.16 Fulgent Genetics
  • 10.16.1 Fulgent Genetics Company Details
  • 10.16.2 Fulgent Genetics Business Overview
  • 10.16.3 Fulgent Genetics Rare Disease Genetic Testing Introduction
  • 10.16.4 Fulgent Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
  • 10.16.5 Fulgent Genetics Recent Development
• 11.17 Myriad Genetics
  • 10.17.1 Myriad Genetics Company Details
  • 10.17.2 Myriad Genetics Business Overview
  • 10.17.3 Myriad Genetics Rare Disease Genetic Testing Introduction
  • 10.17.4 Myriad Genetics Revenue in Rare Disease Genetic Testing Business (2015-2020)
  • 10.17.5 Myriad Genetics Recent Development
• 11.18 LabCorp
  • 10.18.1 LabCorp Company Details
  • 10.18.2 LabCorp Business Overview
  • 10.18.3 LabCorp Rare Disease Genetic Testing Introduction
  • 10.18.4 LabCorp Revenue in Rare Disease Genetic Testing Business (2015-2020)
  • 10.18.5 LabCorp Recent Development
• 11.19 Opko Health
  • 10.19.1 Opko Health Company Details
  • 10.19.2 Opko Health Business Overview
  • 10.19.3 Opko Health Rare Disease Genetic Testing Introduction
  • 10.19.4 Opko Health Revenue in Rare Disease Genetic Testing Business (2015-2020)
  • 10.19.5 Opko Health Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer